Medicine, Chocolate and the ESG Data-verse

Podcast
23 min listen
Cole Martin, Julia Giguere-Morello
November 11, 2022
In this episode

One well-worn critique of ESG investing is that some companies with a high rating aren’t actually making the world a better place. We break down this conflation of ESG impact with financial risk by looking at the different sides of J&J and Nestle.
Listen
Spotify
Apple
YouTube
Transcript
Featuring
Cole Martin
Cole Martin
Senior Associate, MSCI Research
Julia Giguere-Morello
Julia Giguere-Morello
Executive Director, MSCI Research

Subscribe today
to have insights delivered to your inbox.

ESG Now Podcast

ESG explored. A rotating cast of researchers on environmental, social, and governance issues join hosts Mike Disabato and Bentley Kaplan as they discuss the most pressing news of the week. But in an enjoyable way.
Previous episodes

Children in the Cocoa Fields

We begin this episode with an update on the invasion of Ukraine by Russia. Western companies have begun an exodus from Russia as sanctions and atrocities mount. Yet, some are deciding to stay.
Read more

Vaccines over Viagra?

Vaccines over Viagra? Health care companies may be incentivized toward neglected public health priorities in the #postCOVID19 world.
Learn more

The content of this page is for informational purposes only and is intended for institutional professionals with the analytical resources and tools necessary to interpret any performance information. Nothing herein is intended to recommend any product, tool or service. For all references to laws, rules or regulations, please note that the information is provided “as is” and does not constitute legal advice or any binding interpretation. Any approach to comply with regulatory or policy initiatives should be discussed with your own legal counsel and/or the relevant competent authority, as needed.